The role of biologically effective dose (BED) in clinical oncology.
Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DA.
Clin Oncol (R Coll Radiol). 2001;13(2):71-81. doi: 10.1053/clon.2001.9221.
Biologically effective dose (BED) value lower than 120 Gy improve outcomes in lung SBRT.
Jimenez-Jimenez E, Marti-Laosa MM, Nieto-Guerrero JM, Perez ME, Gómez M, Lozano E, Sabater S.
Clin Transl Oncol. 2024 May;26(5):1203-1208. doi: 10.1007/s12094-023-03345-9. Epub 2023 Nov 28.
Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (5 cm).
Sun J, Zhang T, Wang J, Li W, Zhang A, He W, Zhang D, Li D, Ding J, Duan X.
BMC Cancer. 2019 Aug 28;19(1):846. doi: 10.1186/s12885-019-6063-9.
Evaluating the biologically effective dose (BED) concept using a dynamic tumor simulation model.
Dahlman EL, Watanabe Y.
Med Phys. 2020 Aug;47(8):3710-3720. doi: 10.1002/mp.14228. Epub 2020 Jun 8.
The role of the concept of biologically effective dose (BED) in treatment planning in radiosurgery.
Millar WT, Hopewell JW, Paddick I, Lindquist C, Nordströn H, Lidberg P, Gårding J.
Phys Med. 2015 Sep;31(6):627-33. doi: 10.1016/j.ejmp.2015.04.008. Epub 2015 May 14.
Biologically effective dose (BED) escalation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma patients (5 cm) with CyberKnife: protocol of study.
Sun J, Zhang A, Li W, Wang Q, Li D, Zhang D, Duan X.
Radiat Oncol. 2020 Jan 28;15(1):20. doi: 10.1186/s13014-020-1471-1.
Update of human spinal cord reirradiation tolerance based on additional data from 38 patients.
Nieder C, Grosu AL, Andratschke NH, Molls M.
Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1446-9. doi: 10.1016/j.ijrobp.2006.07.1383. Epub 2006 Nov 2.
21 years of biologically effective dose.
Fowler JF.
Br J Radiol. 2010 Jul;83(991):554-68. doi: 10.1259/bjr/31372149.
The Relevance of Biologically Effective Dose for Hearing Preservation After Stereotactic Radiosurgery for Vestibular Schwannomas: A Retrospective Longitudinal Study.
Tuleasca C, Toma-Dasu I, Duroux S, Starnoni D, George M, Maire R, Daniel RT, Patin D, Schiappacasse L, Dasu A, Faouzi M, Levivier M.
Neurosurgery. 2023 Jun 1;92(6):1216-1226. doi: 10.1227/neu.0000000000002352. Epub 2023 Jan 24.
Biologically effective dose correlates with linear tumor volume changes after upfront single-fraction stereotactic radiosurgery for vestibular schwannomas.
Tuleasca C, Faouzi M, Maeder P, Maire R, Knisely J, Levivier M.
Neurosurg Rev. 2021 Dec;44(6):3527-3537. doi: 10.1007/s10143-021-01538-w. Epub 2021 Apr 10.
